The Board of Directors of CSPC Pharmaceutical Group Limited announced that Ms. Li Quan has been appointed as an independent non-executive director of the Company with effect from 8 November 2022. Ms. Li Quan, aged 42, has over ten years of experience in investment management. She is currently the Managing Director of CDH Investments Management (Hong Kong) Limited, responsible for investment in the healthcare sector in the private equity department.

Ms. Li holds a Bachelor of Cell Biology & Genetics and Economics double degree from Peking University, and a Master of Science degree from National University of Singapore School of Computing. She is also a non-executive director of SciClone Pharmaceuticals (Holdings) Limited (stock code: 6600), which is listed on The Stock Exchange of Hong Kong Limited (the "Stock Exchange").